Community Health Sys Stock (NYSE:CYH), Trade Ideas

Community Health Sys

Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.

Community Health Systems

Fifth Third Bancorp - logo

News

Intraday Update

Markets

Movers

ALVO

FITB

HUMA

MNDR

NUVB

PARA

TELL

Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday

Earnings

Penny Stocks

Eurozone

Commodities

Small Cap

Global

Trading Ideas

MOTS

PANW

THRM

UCAR

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 150 points on Wednesday.

The Dow traded down 0.39% to 38,412.53 while the NASDAQ fell 1.06% to 15,464.67. The S&amp;P 500 also fell, dropping, 0.47% to 4,952.19.

Nasdaq Down 1%; Gentherm Shares Spike Higher

AMPL

ATCH

AVGR

BFRI

BLCO

CPOP

EFOI

GBNH

GRMN

HCKT

IOVA

JANX

LIVN

MTTR

PLAB

RAPT

SEDG

SEED

SISI

SNCR

SOGP

TDOC

TRTX

VTYX

WTTR

Shares of  International Flavors &amp; Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly dividend approximately 50% to 40 cents per share.

Why International Flavors &amp; Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Community Health Systems, Inc. Common Stock

Community Health Systems Inc

WIIM

Community Health Systems shares are trading higher after the company reported better-than-expected Q1 financial results.

Assumptions underlying the annual earnings&nbsp;guidance&nbsp;as provided in our press release issued on February 20, 2024 are unchanged.

Guidance

Community Health Systems Reaffirms Annual Earnings Guidance For 2024

Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) reported Adj quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.16) by 12.5 percent. The company reported quarterly sales of $3.140 billion which beat the analyst consensus estimate of $3.093 billion by 1.51 percent. This is a 1.03 percent increase over sales of $3.108 billion the same period last year.

Community Health Sys Q1 2024 Adj EPS $(0.14) Beats $(0.16) Estimate, Sales $3.140B Beat $3.093B Estimate

Options

Community Health Sys Option Alert: Jun 21 $4 Calls Sweep (38) near the Ask: 1118 @ $0.399 vs 1354 OI; Ref=$2.98

U.S. stocks were mixed, with the Nasdaq Composite falling over 100 points on Friday.
Shares of Fifth Third Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FITB#NASDAQ">FITB</a>) rose during Friday's session after the company reported better-than-expected <a href="https://www.benzinga.com/quote/FITB/earnings">quarterly financial results</a>.
Fifth Third Bancorp posted adjusted earnings of 76 cents per share, beating market estimates of 70 cents per share. The company's sales came in at $2.100 billion versus expectations of $2.086 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Fifth Third Bancorp shares gained 4.2% to $35.67 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Mobile-health Network Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDR#NASDAQ">MNDR</a>) shares jumped 20.2% to $24.53.</li>
<li>Metropolitan Bank Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCB#NYSE">MCB</a>) rose 19% to $39.40 after the company reported better-than-expected first-quarter financial results.</li>
<li>Humacyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUMA#NASDAQ">HUMA</a>) climbed 12.2% to $4.03.</li>
<li>Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>) shares rose 9.7% to $12.03 following reports suggesting Sony is in talks with Apollo to join a bid for the company.</li>
<li>Cohen &amp; Steers, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNS#NYSE">CNS</a>) gained 8.1% to $71.48 after it was announced the stock will join the S&amp;P SmallCap 600.</li>
<li>Tellurian Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TELL#NYSE">TELL</a>) shares jumped 7.8% to $0.4172.</li>
<li>Alvotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVO#NASDAQ">ALVO</a>) gained 6.6% to $13.75. Alvotech inked a long-term agreement with a strategic partner to further enhance access to Adalimumab-ryvk in the US market.</li>
<li>Bar Harbor Bankshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHB#NYSE">BHB</a>) climbed 5.6% to $25.20 following upbeat quarterly earnings.</li>
<li>Nuvation Bio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUVB#NYSE">NUVB</a>) rose 5.2% to $2.7150.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) shares rose 4.8% to $3.0589. Wedbush, on Thursday, slashed its price target on the stock to $4 on Thursday.</li>
<li>Community Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) gained 4.7% to $2.9099. Community Health Systems announced an agreement to sell Cleveland, Tennessee, Hospital to Hamilton Health Care System for $160 million in cash.</li>
</ul>
Read More: <a href="https://www.benzinga.com/news/24/04/38334217/netflix-to-rally-around-31-here-are-10-top-analyst-forecasts-for-friday">Netflix To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday</a>

Asset Sales

Community Health Systems Says Transaction Expected To Close In Q3 Of This Year

Community Health Systems Announces Agreement To Sell Cleveland, Tennessee, Hospital To Hamilton Health Care System For $160M In Cash

CHS Becomes First Health System to Purchase Drugs Manufactured by Cost Plus Drugs
Community Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) (CHS) will become the first national healthcare system to purchase select pharmaceutical supplies from Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) as part of a new, collaborative relationship that promises to bring high-quality, lower cost drugs into the hospital setting.
The onset of the partnership coincides with the opening of a state-of-the-art, 22,000-square-foot, fill and finish drug manufacturing plant, owned and operated by Cost Plus Drugs, in Dallas, Texas. The plant is equipped with aseptic robotic filling lines that produce lifesaving injectable medications.
Initially, CHS-affiliated hospitals in Texas and Pennsylvania will purchase pharmaceuticals such as epinephrine and norepinephrine, drugs that are often used to treat life threatening conditions and serious illnesses, especially in emergency departments and intensive care units. The Food and Drug Administration includes epinephrine on its list of current drug shortages due to increased demand and manufacturing delays.
CHS and Cost Plus Drugs will work collaboratively to address critically important issues related to drug supply in the hospital setting, including:
<ul>
<li>Rising costs of pharmaceuticals – Cost Plus Drugs is committed to supplying drugs at a lower price point with minimal mark-up, which helps hospitals manage inflationary pressures as the cost of providing patient care continues to climb.</li>
<li>Drug shortages – Cost Plus Drugs is focused on manufacturing drugs that are often in limited supply, threatening patient treatment and outcomes when shortages occur. CHS and Cost Plus Drugs are working together to identify, prepare for, and mitigate potential future drug shortages in the hospital setting.</li>
<li>Pharmaceutical waste – Cost Plus Drugs offers CHS-affiliated hospitals more flexible ordering opportunities, including alternative vial sizes for drug administration, which can reduce waste and help hospitals order and maintain drug supplies in quantities that are most efficient for their unique needs and the specific services they offer.</li>
<li>Patient safety and medication error prevention – Because Cost Plus Drugs will provide drugs in vial sizes that many other drug manufacturers won't offer, there is less potential for dosage errors when drugs must be measured prior to administration at the bedside.</li>
</ul>
"There are many opportunities for innovation in the healthcare industry, including rethinking, and even disrupting, the way providers purchase products and services," said Lynn Simon, MD, President of Healthcare Innovation and Chief Medical Officer at Community Health Systems. "Our relationship with Mark Cuban Cost Plus Drug Company has the potential to generate significant advantages for our affiliated hospitals and for other forward-looking hospital organizations that also want to reduce costs, reduce waste, avoid drug shortages, and improve patient care."
With a footprint of more than 70-acute care hospitals and hundreds of other care locations, including ambulatory surgery centers, freestanding ERs, and physician practices, CHS and Cost Plus Drugs expect to scale the partnership in numerous and meaningful ways.
"Community Health Systems has stepped forward to consider important issues related to drug supply, drug costs, patient care and outcomes," said Alex Oshmyansky, MD, PhD, Chief Executive Officer of Mark Cuban Cost Plus Drug Company. "This partnership has the potential to shine a light on all of the ways Cost Plus Drugs can work with like-minded providers to create a better approach to drug delivery in hospitals and in multiple care delivery environments."
Commenting on the strategic partnership, Mark Cuban said, "We are excited to start shipping our first sterile injectables from our Cost Plus Factory. Our mission is to end drug shortages and this is just the first step. Our partnership with CHS will give them access to epinephrine and norepinephrine at a transparent cost plus price. This is the start of what we know will be an amazing partnership that will reduce drug shortages and drug costs and enhance the care CHS hospitals provide for their patients."

Community Health Systems Partners With Mark Cuban Cost Plus Drug Company As Part Of A New, Collaborative Relationship That Promises To Bring High-Quality, Lower Cost Drugs Into The Hospital Setting

Barclays analyst Andrew Mok initiates coverage on Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) with a Equal-Weight rating and announces Price Target of $3.

Price Target

Initiation

Analyst Ratings

Barclays Initiates Coverage On Community Health Sys with Equal-Weight Rating, Announces Price Target of $3

<a href="https://www.statnews.com/2024/02/22/community-health-systems-hospitals-doj-billing/?utm_campaign=rss" title="https://www.statnews.com/2024/02/22/community-health-systems-hospitals-doj-billing/?utm_campaign=rss">https://www.statnews.com/2024/02/22/community-health-systems-hospitals-doj-billing/?utm_campaign=rss</a>

'DOJ investigating Community Health Systems' hospitals' -Stat News

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 150 points on Wednesday.
The Dow traded down 0.39% to 38,412.53 while the NASDAQ fell 1.06% to 15,464.67. The S&amp;P 500 also fell, dropping, 0.47% to 4,952.19.
Check This Out: <a href="https://www.benzinga.com/news/24/02/37210537/top-4-tech-stocks-that-may-crash-this-month"> Top 4 Tech Stocks That May Crash This Month</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Energy shares rose by 1.7% on Wednesday.
In trading on Wednesday, information technology shares fell by 1.7%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
The minutes from the latest Federal Open Market Committee (FOMC) meeting underscored the Federal Reserve&rsquo;s commitment to await more concrete evidence of a disinflationary trend before contemplating interest rate reductions.
According to the Fed statement, the FOMC emphasized that it anticipates maintaining interest rates steady &ldquo;until it has gained greater confidence that inflation is moving sustainably toward 2%.&rdquo;
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
MediaAlpha, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/max#NYSE">MAX</a>) shares shot up 23% to $19.43 after the company reported better-than-expected fourth-quarter financial results.
Shares of Gentherm Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thrm#NASDAQ">THRM</a>) got a boost, surging 20% to $58.91 after the company reported better-than-expected fourth-quarter financial results and issued guidance.
Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) shares were also up, gaining 64% to $1.0701 after the company was granted U.S. Patent #11904085 for &#39;Systems And Methods For Cleaning A Colon.&#39;
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Palo Alto Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/panw#NASDAQ">PANW</a>) shares dropped 28% to $263.05 after the company issued third-quarter adjusted EPS and total revenue guidance below estimates.
Shares of U Power Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ucar#NASDAQ">UCAR</a>) were down 26% to $0.0758 after the company received a delisting notice from the Nasdaq Stock Market due to its ordinary shares&rsquo; closing bid price falling below $0.10 for ten consecutive trading days, as per the Low Priced Stocks Rule.
Community Health Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cyh#NYSE">CYH</a>) was down, falling 27% to $2.9350 after the company reported fourth-quarter financial results.
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded up 1.2% to $77.94 while gold traded down 0.2% at $2,035.50.
Silver traded down 0.9% to $22.925 on Wednesday while copper rose 0.2% to $3.8745.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares closed mostly higher today. The eurozone&rsquo;s STOXX 600 fell 0.17%, London&rsquo;s FTSE 100 fell 0.73% while Spain&rsquo;s IBEX 35 Index rose 0.69% The German DAX gained 0.29% French CAC 40 rose 0.22% while Italy&rsquo;s FTSE MIB Index rose 1.00%.
The Confederation of British Industry survey&#39;s total order book balance climbed by 10 points to a reading of -20 in February.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mixed on Wednesday, with Japan&rsquo;s Nikkei 225 falling 0.26%, Hong Kong&rsquo;s Hang Seng Index rising 1.57%, China&rsquo;s Shanghai Composite Index gaining 0.97% and India&rsquo;s S&amp;P BSE Sensex falling 0.59%.
Japanese trade deficit narrowed to JPY 1,758.311 billion in January from JPY 3,506.43 billion in the year-ago month. Exports from Japan surged by 11.9% year-over-year, while imports to Japan dipped 9.6% year-over-year.
&nbsp;
<h3>Economics</h3>
&nbsp;
U.S. mortgage applications fell by 10.6% on the week ending Feb. 16, 2024.
Now Read This: <a href="https://www.benzinga.com/news/24/02/37209778/starbucks-regeneron-pharmaceuticals-and-2-other-stocks-insiders-are-selling"> Starbucks, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling</a>

Shares of International Flavors &amp; Fragrances Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iff#NYSE">IFF</a>) fell during Wednesday&rsquo;s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly dividend approximately 50% to 40 cents per share.
International Flavors &amp; Fragrances shares dipped 8.4% to $75.11 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Greenbrook TMS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbnh#NASDAQ">GBNH</a>) climbed 120.8% to $0.4351. Greenbrook TMS raised $2.5 million in debt financing.</li>
<li>Emergent BioSolutions Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ebs#NYSE">EBS</a>) gained 84% to $2.8050. Emergent BioSolutions appointed Joseph Papa as President and CEO, effective Feb. 21, 2024.</li>
<li>Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) gained 77.2% to $5.30. Traders circulated unconfirmed analyst comments suggesting co might be the next big weight loss drug citing a new publication showing NLRP3 has significant weight loss similar to GLP-1.</li>
<li>Sound Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sogp#NASDAQ">SOGP</a>) shares rose 63.1% to $4.60. Sound Group announced the launch of new AI-powered applications.</li>
<li>Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) shares rose 59.4% to $1.04 after the company was granted U.S. Patent #11904085 for &#39;Systems And Methods For Cleaning A Colon.&#39;</li>
<li>Origin Agritech Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seed#NASDAQ">SEED</a>) gained 34% to $3.11. Origin Agritech increased revenue by 77% year-over-year for the fiscal year ended Sep. 30, 2023.</li>
<li>Gentherm Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thrm#NASDAQ">THRM</a>) shares jumped 24.7% to $61.48 after the company reported better-than-expected fourth-quarter financial results and issued guidance.</li>
<li>RAPT Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rapt#NASDAQ">RAPT</a>) gained 24% to $8.52.</li>
<li>Energy Focus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/efoi#NASDAQ">EFOI</a>) shares jumped 23.4% to $1.7050.</li>
<li>MediaAlpha, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/max#NYSE">MAX</a>) rose 19% to $18.80 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Janux Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/janx#NASDAQ">JANX</a>) gained 18% to $11.75. Janux Therapeutics will host virtual event on Feb. 26th, 2024, at 4:30PM ET to discuss updated clinical data for PSMA-TRACTr JANX007 and EGFR-TRACTr JANX008.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iova#NASDAQ">IOVA</a>) rose 15.9% to $13.95.</li>
<li>TPG RE Finance Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trtx#NYSE">TRTX</a>) jumped 12.9% to $6.24 after the company reported fourth-quarter financial results.</li>
<li>Garmin Ltd.(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/grmn#NYSE">GRMN</a>) rose 12.2% to $137.72 after the company reported fourth-quarter financial results and issued FY24 revenue guidance above estimates, recommended boosting annual dividend and authorized share buyback.</li>
<li>Select Water Solutions, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wttr#NYSE">WTTR</a>) gained 11.7% to $8.77 following strong earnings.</li>
<li>The Hackett Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hckt#NASDAQ">HCKT</a>) surged 11.2% to $25.48 following upbeat results.</li>
<li>LivaNova PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/livn#NASDAQ">LIVN</a>) jumped 8.8% to $57.28 following upbeat earnings.</li>
<li>EQT Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eqt#NYSE">EQT</a>) gained 8.8% to $36.69.</li>
<li>Wix.com Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wix#NASDAQ">WIX</a>) gained 8.6% to $136.15 following fourth-quarter results.</li>
<li>Bausch + Lomb Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/blco#NYSE">BLCO</a>) gained 8.6% to $15.84 after reporting quarterly results.</li>
<li>Wix.com Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wix#NASDAQ">WIX</a>) gained 8.2% to $135.56 following fourth-quarter results.</li>
<li>NeoGenomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/neo#NASDAQ">NEO</a>) rose 7.4% to $15.78 after the company reported better-than-expected fourth-quarter financial results and issued FY24 adjusted EPS guidance above estimates.</li>
<li>Toll Brothers, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tol#NYSE">TOL</a>) gained 6.6% to $110.42 after the company reported better-than-expected first-quarter financial results and issued FY24 EPS guidance above estimates.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>AtlasClear Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atch#NYSE">ATCH</a>) shares tumbled 41% to $1.19.</li>
<li>Shineco, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sisi#NASDAQ">SISI</a>) dipped 33.4% to $1.53 after gaining around 56% on Tuesday.</li>
<li>Synchronoss Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sncr#NASDAQ">SNCR</a>) fell 32.2% to $8.30.</li>
<li>U Power Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ucar#NASDAQ">UCAR</a>) dipped 30% to $0.0710 after the company received a delisting notice from the Nasdaq Stock Market due to its ordinary shares&rsquo; closing bid price falling below $0.10 for ten consecutive trading days, as per the Low Priced Stocks Rule.</li>
<li>MoneyHero Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mny#NASDAQ">MNY</a>) fell 28% to $2.2259.</li>
<li>Community Health Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cyh#NYSE">CYH</a>) fell 27.3% to $2.9350 after the company reported fourth-quarter financial results.</li>
<li>Palo Alto Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/panw#NASDAQ">PANW</a>) shares dipped 26.2% to $270.29 after the company issued third-quarter guidance below estimates.</li>
<li>Teladoc Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tdoc#NYSE">TDOC</a>) shares fell 25.3% to $15.31 after the company reported mixed fourth-quarter financial results and issued weak guidance.</li>
<li>Unisys Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uis#NYSE">UIS</a>) fell 24.5% to $5.88 after the company reported quarterly financial results.</li>
<li>Pop Culture Group Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cpop#NASDAQ">CPOP</a>) fell 21.3% to $5.66 after jumping 171% on Tuesday.</li>
<li>Amplitude, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ampl#NASDAQ">AMPL</a>) fell 16.6% to $11.73 after the company reported mixed fourth-quarter financial results and issued weak guidance.</li>
<li>SolarEdge Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sedg#NASDAQ">SEDG</a>) shares fell 15.7% to $71.20 after the company reported mixed fourth-quarter financial results.</li>
<li>Matterport, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mttr#NASDAQ">MTTR</a>) shares fell 15.4% to $2.1450 after the company posted weak quarterly sales and issued downbeat forecast.</li>
<li>Zscaler, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zs#NASDAQ">ZS</a>) fell 14.8% to $212.15.</li>
<li>Medifast, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/med#NYSE">MED</a>) declined 14.3% to $41.95 after the company issued weak guidance.</li>
<li>Avinger, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avgr#NASDAQ">AVGR</a>) shares fell 14.3% to $4.57 after surging 83% on Tuesday.</li>
<li>Photronics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plab#NASDAQ">PLAB</a>) fell 13% to $27.17 after the company reported first-quarter financial results below estimates.</li>
<li>Workiva Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wk#NYSE">WK</a>) fell 12.3% to $82.55 following quarterly results.</li>
<li>Fisker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsr#NYSE">FSR</a>) fell 11.4% to $0.5582.</li>
<li>Biofrontera Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfri#NASDAQ">BFRI</a>) shares fell 6.1% to $1.0794. Biofrontera shares jumped 53% on Tuesday after the company announced a private placement of up to $16 million priced at the market per Nasdaq rules.</li>
<li>Sprout Social, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spt#NASDAQ">SPT</a>) shares declined 5.4% to $61.01 after the company reported fourth-quarter financial results and issued guidance.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/02/37237721/bitcoin-falls-below-51-000-starknet-becomes-top-loser"> Bitcoin Falls Below $51,000; Starknet Becomes Top Loser</a>

Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) stock increased by 77.0% to $2.69 during Wednesday's regular session. The market value of their outstanding shares is at $139.5 million. </li>
<li>Ventyx Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTYX#NASDAQ">VTYX</a>) shares moved upwards by 72.07% to $5.14. The market value of their outstanding shares is at $303.8 million. </li>
<li>Motus GI Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOTS#NASDAQ">MOTS</a>) stock increased by 54.07% to $1.0. The company's market cap stands at $1.5 million. </li>
<li>Janux Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JANX#NASDAQ">JANX</a>) shares increased by 35.54% to $13.5. The market value of their outstanding shares is at $623.2 million. </li>
<li>RAPT Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPT#NASDAQ">RAPT</a>) stock rose 26.05% to $8.66. The company's market cap stands at $297.8 million. </li>
<li>Iovance Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) stock rose 24.1% to $14.93. The company's market cap stands at $3.8 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) shares fell 29.2% to $0.37 during Wednesday's regular session. The market value of their outstanding shares is at $3.4 million. </li>
<li>PHAXIAM Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHXM#NASDAQ">PHXM</a>) shares decreased by 26.33% to $2.79. The company's market cap stands at $16.9 million. </li>
<li>Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) stock decreased by 25.87% to $3.0. The company's market cap stands at $409.7 million. The company's, Q4 earnings came out yesterday. </li>
<li>Teladoc Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) shares fell 25.21% to $15.32. The company's market cap stands at $2.5 billion. The company's, Q4 earnings came out yesterday. </li>
<li>Kazia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZIA#NASDAQ">KZIA</a>) shares declined by 24.39% to $0.3. The market value of their outstanding shares is at $7.9 million. </li>
<li>NKGen Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKGN#NASDAQ">NKGN</a>) stock decreased by 20.64% to $1.0. The company's market cap stands at $21.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BSGM

KZIA

NKGN

PHXM

12 Health Care Stocks Moving In Wednesday's Intraday Session

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 0.5% on Wednesday.
The Dow traded down 0.16% to 38,503.94 while the NASDAQ fell 0.47% to 15,557.94. The S&amp;P 500 also fell, dropping, 0.11% to 4,969.94.
Check This Out: <a href="https://www.benzinga.com/news/24/02/37210537/top-4-tech-stocks-that-may-crash-this-month"> Top 4 Tech Stocks That May Crash This Month</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Energy shares rose by 1.5% on Wednesday.
In trading on Wednesday, information technology shares fell by 1%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Exelon Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exc#NASDAQ">EXC</a>) reported better-than-expected fourth-quarter financial results and increased its quarterly dividend.
Exelon reported fourth-quarter fiscal 2023 operating revenue growth of 15% year-over-year to $5.37 billion, beating the estimates of $4.17 billion. Adjusted EPS improved to 60 cents from 43 cents in 2022, beating the estimate of 58 cents.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
MediaAlpha, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/max#NYSE">MAX</a>) shares shot up 18% to $18.71 after the company reported better-than-expected fourth-quarter financial results.
Shares of Gentherm Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thrm#NASDAQ">THRM</a>) got a boost, surging 23% to $60.65 after the company reported better-than-expected fourth-quarter financial results and issued guidance.
Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) shares were also up, gaining 58% to $1.0326 after the company was granted U.S. Patent #11904085 for &#39;Systems And Methods For Cleaning A Colon.&#39;
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Palo Alto Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/panw#NASDAQ">PANW</a>) shares dropped 27% to $268.49 after the company issued third-quarter adjusted EPS and total revenue guidance below estimates.
Shares of U Power Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ucar#NASDAQ">UCAR</a>) were down 30% to $0.0716 after the company received a delisting notice from the Nasdaq Stock Market due to its ordinary shares&rsquo; closing bid price falling below $0.10 for ten consecutive trading days, as per the Low Priced Stocks Rule.
Community Health Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cyh#NYSE">CYH</a>) was down, falling 26% to $2.97 after the company reported fourth-quarter financial results.
Also Check This Out:<a href="https://www.benzinga.com/news/24/02/37210908/alaska-air-to-rally-around-36-here-are-10-top-analyst-forecasts-for-tuesday"> Alaska Air To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded up 0.6% to $77.52 while gold traded down 0.3% at $2,034.40.
Silver traded down 1.1% to $22.88 on Wednesday while copper rose 0.1% to $3.8730.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were mostly higher today. The eurozone&rsquo;s STOXX 600 fell 0.22%, London&rsquo;s FTSE 100 fell 0.75% while Spain&rsquo;s IBEX 35 Index rose 0.67% The German DAX gained 0.22% French CAC 40 rose 0.17% while Italy&rsquo;s FTSE MIB Index rose 1%.
The Confederation of British Industry survey&#39;s total order book balance climbed by 10 points to a reading of -20 in February.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mixed on Wednesday, with Japan&rsquo;s Nikkei 225 falling 0.26%, Hong Kong&rsquo;s Hang Seng Index rising 1.57%, China&rsquo;s Shanghai Composite Index gaining 0.97% and India&rsquo;s S&amp;P BSE Sensex falling 0.59%.
Japanese trade deficit narrowed to JPY 1,758.311 billion in January from JPY 3,506.43 billion in the year-ago month. Exports from Japan surged by 11.9% year-over-year, while imports to Japan dipped 9.6% year-over-year.
&nbsp;
<h3>Economics</h3>
&nbsp;
U.S. mortgage applications fell by 10.6% on the week ending Feb. 16, 2024.
Now Read This: <a href="https://www.benzinga.com/news/24/02/37209778/starbucks-regeneron-pharmaceuticals-and-2-other-stocks-insiders-are-selling"> Starbucks, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling</a>

Crude Oil Moves Higher; Exelon Earnings Top Estimates

U.S. stocks traded lower this morning, with the Dow Jones index falling over 100 points on Wednesday.
Following the market opening Wednesday, the Dow traded down 0.31% to 38,443.33 while the NASDAQ fell 0.58% to 15,540.19. The S&amp;P 500 also fell, dropping, 0.28% to 4,961.55.
Check This Out: <a href="https://www.benzinga.com/news/24/02/37210537/top-4-tech-stocks-that-may-crash-this-month"> Top 4 Tech Stocks That May Crash This Month</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Consumer discretionary shares rose by 0.8% on Wednesday.
In trading on Wednesday, information technology shares fell by 1%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Analog Devices, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adi#NASDAQ">ADI</a>) posted upbeat first-quarter earnings, but issued a weak forecast for the current quarter.
Analog Devices posted adjusted earnings of $1.73 per share, beating market estimates of $1.71 per share. The company&rsquo;s quarterly sales came in at $2.51 billion versus expectations of $2.50 billion.
Analog Devices said it sees second-quarter adjusted EPS of $1.16 to $1.36 versus estimates of $1.57. The company expects revenue of $2 billion to $2.2 billion versus expectations of $2.36 billion.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Greenbrook TMS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbnh#NASDAQ">GBNH</a>) shares shot up 136% to $0.4650. Greenbrook TMS raised $2.5 million in debt financing.
Shares of Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) got a boost, surging 100% to $5.98. Traders circulated unconfirmed analyst comments suggesting co might be the next big weight loss drug citing a new publication showing NLRP3 has significant weight loss similar to GLP-1.
Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) shares were also up, gaining 88% to $1.2288 after the company was granted U.S. Patent #11904085 for &#39;Systems And Methods For Cleaning A Colon.&#39;
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Palo Alto Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/panw#NASDAQ">PANW</a>) shares dropped 26% to $271.52 after the company issued third-quarter adjusted EPS and total revenue guidance below estimates.
Shares of U Power Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ucar#NASDAQ">UCAR</a>) were down 27% to $0.0743. 
U Power received Nasdaq delisting notification and intends to appeal.
Community Health Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cyh#NYSE">CYH</a>) was down, falling 28% to $2.9186 after the company reported fourth-quarter financial results.
Also Check This Out:<a href="https://www.benzinga.com/news/24/02/37210908/alaska-air-to-rally-around-36-here-are-10-top-analyst-forecasts-for-tuesday"> Alaska Air To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded up 0.4% to $77.34 while gold traded up 0.1% at $2,040.80.
Silver traded down 0.3% to $23.065 on Wednesday while copper rose 1% to $3.9050.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were mostly higher today. The eurozone&rsquo;s STOXX 600 fell 0.2%, London&rsquo;s FTSE 100 fell 0.8% while Spain&rsquo;s IBEX 35 Index rose 0.5% The German DAX gained 0.4% French CAC 40 rose 0.1% while Italy&rsquo;s FTSE MIB Index rose 0.9%.
The Confederation of British Industry survey&#39;s total order book balance climbed by 10 points to a reading of -20 in February.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mixed on Wednesday, with Japan&rsquo;s Nikkei 225 falling 0.26%, Hong Kong&rsquo;s Hang Seng Index rising 1.57%, China&rsquo;s Shanghai Composite Index gaining 0.97% and India&rsquo;s S&amp;P BSE Sensex falling 0.59%.
Japanese trade deficit narrowed to JPY 1,758.311 billion in January from JPY 3,506.43 billion in the year-ago month. Exports from Japan surged by 11.9% year-over-year, while imports to Japan dipped 9.6% year-over-year.
&nbsp;
<h3>Economics</h3>
&nbsp;
U.S. mortgage applications fell by 10.6% on the week ending Feb. 16, 2024.
Now Read This: <a href="https://www.benzinga.com/news/24/02/37209778/starbucks-regeneron-pharmaceuticals-and-2-other-stocks-insiders-are-selling"> Starbucks, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling</a>

Dow Dips Over 100 Points; Analog Devices Posts Upbeat Earnings

Community Health Systems shares are trading lower after the company reported Q4 financial results.

Shares of NeoGenomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/neo#NASDAQ">NEO</a>) rose sharply in today&rsquo;s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY24 adjusted EPS guidance above estimates.
NeoGenomics posted adjusted earnings of 3 cents per share, compared to market expectations for a loss of 2 cents per share. The company&rsquo;s quarterly sales came in at $155.55 million versus estimates of $152.54 million.
NeoGenomics shares surged 12.9% to $16.60 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
Greenbrook TMS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbnh#NASDAQ">GBNH</a>) gained 163% to $0.5181 in pre-market trading. Greenbrook TMS raised $2.5 million in debt financing.
CN Energy Group. Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cney#NASDAQ">CNEY</a>) shares surged 100% to $2.66 in pre-market trading. CN Energy Group recently named Steven Berman as Chief Executive Officer.
Sound Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sogp#NASDAQ">SOGP</a>) shares rose 96.8% to $5.55 in pre-market trading. Sound Group announced the launch of new AI-powered applications.
Energy Focus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/efoi#NASDAQ">EFOI</a>) shares jumped 96.4% to $2.71 in pre-market trading.
Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) shares rose 38.8% to $0.9052 in pre-market trading after the company was granted U.S. Patent #11904085 for &#39;Systems And Methods For Cleaning A Colon.&#39;
MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) shares gained 23.1% to $20.20 in pre-market trading after dipping 75% on Tuesday.
Intuitive Machines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lunr#NASDAQ">LUNR</a>) gained 21.8% to $13.39 in pre-market trading after jumping 50% on Tuesday.
JX Luxventure Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jxjt#NASDAQ">JXJT</a>) gained 14.2% to $2.57 in pre-market trading.
Wix.com Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wix#NASDAQ">WIX</a>) gained 6.5% to $133.51 in pre-market trading following fourth-quarter results.
<h3>Losers</h3>
Pop Culture Group Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cpop#NASDAQ">CPOP</a>) fell 32.5% to $4.85 in pre-market trading after jumping 171% on Tuesday.
Avinger, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avgr#NASDAQ">AVGR</a>) shares fell 25.3% to $3.99 in pre-market trading after surging 83% on Tuesday.
Shineco, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sisi#NASDAQ">SISI</a>) dipped 24.4% to $1.74 in pre-market trading after gaining around 56% on Tuesday.
Palo Alto Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/panw#NASDAQ">PANW</a>) shares dipped 23.1% to $281.39 in pre-market trading after the company issued third-quarter guidance below estimates.
Teladoc Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tdoc#NYSE">TDOC</a>) shares fell 22.4% to $15.91 after the company reported mixed fourth-quarter financial results and issued weak guidance.
Biofrontera Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfri#NASDAQ">BFRI</a>) shares fell 18.4% to $0.9387 in pre-market trading. Biofrontera shares jumped 53% on Tuesday after the company announced a private placement of up to $16 million priced at the market per Nasdaq rules.
Community Health Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cyh#NYSE">CYH</a>) fell 18.3% to $3.30 in pre-market trading after the company reported fourth-quarter financial results.
SolarEdge Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sedg#NASDAQ">SEDG</a>) shares fell 15.7% to $71.20 after the company reported mixed fourth-quarter financial results.
Matterport, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mttr#NASDAQ">MTTR</a>) shares fell 15.4% to $2.1450&nbsp;after the company posted weak quarterly sales and issued downbeat forecast.
Sprout Social, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spt#NASDAQ">SPT</a>) shares declined 9.2% to $58.50 in pre-market trading after the company reported fourth-quarter financial results and issued guidance.
&nbsp;
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/02/37229857/nvidia-la-z-boy-and-3-stocks-to-watch-heading-into-wednesday"> Nvidia, La-Z-Boy And 3 Stocks To Watch Heading Into Wednesday</a>

Pre-Market Outlook

CNEY

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

JXJT

LUNR

Why NeoGenomics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

U.S. stock futures were lower this morning, with the Dow futures trading lower by around 70 points on Wednesday.
Shares of Palo Alto Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/panw#NASDAQ">PANW</a>) fell sharply in today&rsquo;s pre-market trading after the company issued third-quarter <a href="https://www.benzinga.com/news/earnings/24/02/37223409/palo-alto-networks-q2-earnings-eps-beat-revenue-up-19-soft-guidance-and-more">guidance below estimates</a>.
Palo Alto&rsquo;s fiscal second-quarter revenue increased 19% year-over-year to $1.98 billion, which beat the consensus estimate of $1.97 billion, according to Benzinga Pro. The company reported quarterly earnings of $1.46 per share, which beat analyst estimates of $1.30 per share.
Palo Alto sees fiscal third-quarter revenue of $1.95 billion to $1.98 billion versus estimates of $2.04 billion. The company expects third-quarter adjusted earnings to be between $1.24 and $1.26 per share versus estimates of $1.29 per share.
Palo Alto Networks shares tumbled 22.1% to $285.06 in pre-market trading.
Here are some big stocks recording losses in today&rsquo;s pre-market trading session.
<ul>
<li>Teladoc Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tdoc#NYSE">TDOC</a>) shares dipped 20.8% to $16.22 in pre-market trading after the company reported mixed fourth-quarter financial results and issued weak guidance.</li>
<li>Community Health Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cyh#NYSE">CYH</a>) fell 18.3% to $3.30 in pre-market trading after the company reported fourth-quarter financial results.</li>
<li>SolarEdge Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sedg#NASDAQ">SEDG</a>) shares fell 16% to $70.90 in pre-market trading after the company reported mixed fourth-quarter financial results.</li>
<li>Matterport, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mttr#NASDAQ">MTTR</a>) shares declined 12.6% to $2.22 in pre-market trading after the company posted weak quarterly sales and issued downbeat forecast.</li>
<li>Calliditas Therapeutics AB (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/calt#NASDAQ">CALT</a>) fell 9.3% to $18.98 in pre-market trading following quarterly results.</li>
<li>CrowdStrike Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crwd#NASDAQ">CRWD</a>) shares fell 9.2% to $294.00 in pre-market trading.</li>
<li>Sprout Social, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spt#NASDAQ">SPT</a>) fell 9.2% to $58.50 in pre-market trading after the company reported fourth-quarter financial results and issued guidance.</li>
<li>Zscaler, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zs#NASDAQ">ZS</a>) fell 9.2% to $226.15 in pre-market trading.</li>
<li>HSBC Holdings plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hsbc#NYSE">HSBC</a>) fell 7.6% to $37.73 in pre-market trading following fourth-quarter results.</li>
<li>Medifast, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/med#NYSE">MED</a>) fell 7.3% to $45.36 in pre-market trading after the company issued weak guidance.</li>
<li>Keysight Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/keys#NYSE">KEYS</a>) declined 6.8% to $144.00 in pre-market trading after the company issued second-quarter EPS and revenue guidance below estimates.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/02/37229881/investor-sentiment-falls-further-fear-greed-index-in-greed-zone"> Investor Sentiment Falls Further; Fear &amp; Greed Index In &#39;Greed&#39; Zone </a>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

CALT

CRWD

HSBC

KEYS

Palo Alto Networks Issues Weak Outlook, Joins Teladoc Health, SolarEdge Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Motus GI Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOTS#NASDAQ">MOTS</a>) shares rose 53.3% to $1.0 during Tuesday's after-market session. The company's market cap stands at $1.5 million. </li>
<li>Acutus Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFIB#NASDAQ">AFIB</a>) shares increased by 39.45% to $0.33. The company's market cap stands at $9.8 million. </li>
<li>Clearside Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSD#NASDAQ">CLSD</a>) shares rose 12.39% to $1.45. The market value of their outstanding shares is at $108.3 million. </li>
<li>NeoGenomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEO#NASDAQ">NEO</a>) stock increased by 11.42% to $16.38. The market value of their outstanding shares is at $2.0 billion. The company's, Q4 earnings came out today. </li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) stock moved upwards by 9.09% to $1.92. The company's market cap stands at $7.0 million. </li>
<li>Apyx Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APYX#NASDAQ">APYX</a>) stock moved upwards by 8.37% to $2.34. The company's market cap stands at $81.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) shares decreased by 14.9% to $3.44 during Tuesday's after-market session. The company's market cap stands at $470.5 million. As per the news, the Q4 earnings report came out today. </li>
<li>Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) shares fell 13.86% to $4.6. The company's market cap stands at $5.8 million. </li>
<li>Teladoc Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) shares declined by 13.23% to $17.78. The company's market cap stands at $2.9 billion. As per the news, the Q4 earnings report came out today. </li>
<li>Biofrontera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFRI#NASDAQ">BFRI</a>) stock fell 11.31% to $1.02. The company's market cap stands at $1.7 million. </li>
<li>Monopar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNPR#NASDAQ">MNPR</a>) shares declined by 7.75% to $0.62. The company's market cap stands at $9.1 million. </li>
<li>Chemomab Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMMB#NASDAQ">CMMB</a>) shares decreased by 7.47% to $0.62. The company's market cap stands at $6.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AFIB

APYX

CLSD

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

MNPR

12 Health Care Stocks Moving In Tuesday's After-Market Session

Moody's cites credit impact to U.S. providers from UnitedHealth cyberattack

Moody's cites credit impact on U.S. providers from UnitedHealth cyberattack

Biden administration issues new ruling against junk health insurance

Barclays analyst Andrew Mok CFA maintained a Hold rating on Community Health (CYH – Research Report) today and set a price target of $3.00. The com...

Barclays Sticks to Its Hold Rating for Community Health (CYH)

Community Health Systems to sell Cleveland, Tennessee, Hospital to Hamilton Health Care System

Community Health Systems Q1 2024 Earnings Preview

Community Health Systems Non-GAAP EPS of -$0.14 in-line, revenue of $3.14B beats by $50M

Community Health (CYH) just unveiled an update. The Company has released its operating results for the first quarter, ending March 31, 2024. This l...

Community Health Q1 2024 Earnings and Business Update

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Community Health Sys (NYSE:<a href="https://investorplace.com/stock-quotes/cyh-stock-quote/">CYH</a>) just reported results for the first quarter of 2024.<ul><li>Community Health Sys reported earnings per share of -14 cents. This was above the analyst estimate for EPS of -16 cents.</li><li>The company reported revenue of $3.14 billion.</li><li>This was 1.62% better than the analyst estimate for revenue of $3.09 billion.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/04/cyh-stock-earnings-community-health-sys-for-q1-of-2024/">CYH Stock Earnings: Community Health Sys Beats EPS, Beats Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

CYH Stock Earnings: Community Health Sys Beats EPS, Beats Revenue for Q1 2024

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amneal Pharmaceuticals (AMRX – Research Report) and Community Hea...

Analysts Conflicted on These Healthcare Names: Amneal Pharmaceuticals (AMRX) and Community Health (CYH)

ACHC

AMRX

LFST

SGRY

Press Releases

Community Health Systems Addresses Health Disparities through Doctors' Day Donations and Second Annual Jars of Love Peanut Butter Drive

Legal

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health, Inc. - CYH

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health, Inc. - CYH

Community Health Systems to Webcast First Quarter 2024 Conference Call

Community Health Systems Announces Definitive Agreement to Sell Cleveland, Tennessee, Hospital to Hamilton Health Care System

Community Health Systems, Inc. Announces First Quarter Ended March 31, 2024 Results